972
Participants
Start Date
July 31, 2008
Primary Completion Date
January 31, 2010
Study Completion Date
June 30, 2010
Dapagliflozin
Tablets, Oral, 5.0 mg, once daily, up to 48 weeks
Dapagliflozin
Tablets, Oral, 10.0 mg, once daily, up to 48 weeks
Placebo matching Dapagliflozin
Tablets, Oral, 0 mg, once daily, up to 48 weeks
Thiazolidinedione (Pioglitazone)
Tablets, ≥ 30 mg, Once daily, up to 48 weeks
Local Institution, Lima
Local Institution, Lima
Local Institution, Taipei
Local Institution, Changhua
Local Institution, Manila
Local Institution, Pasig
Local Institution, Zárate
Local Institution, Córdoba
Local Institution, Cebu City
Finger Lakes Clinical Research, Rochester
Banksville Medical, Pc, Pittsburgh
Family Medical Associates, Levittown
Brookside Family Practice & Pediatrics, Pottstown
Tidewater Integrated Medical Research, Virginia Beach
Metrolina Internal Medicine, Charlotte
The Center For Nutrition & Preventive Medicine, Pllc, Charlotte
New Hanover Medical Research, Wilmington
Northstate Clinical Research, Lenoir
Columbia Clinical Research, Inc., Columbia
Southeastern Research Associates, Inc., Taylors
Stone Mountain Clinical Research, Stone Mountain
Local Institution, Chihuahua City
Westside Center For Clinical Research, Jacksonville
Health First Clinical Research Group, Inc., Chipley
Panhandle Family Care Associates, Marianna
Central Florida Clinical Trials, Altamonte Springs
Clinical Therapeutics Corporation, Coral Gables
Baptist Diabetes Associates, Pa, Miami
Suncoast Clinical Res Inc., New Port Richey
Pinnacle Research Group, Llc, Anniston
Iicr, Ozark
Holston Medical Group, Kingsport
Olive Branch Family Medical Center, Olive Branch
Danny W. Jackson P.A., Rolling Fork
Endocrine Research Associates, Jackson
Local Institution, Taichung
Physician Research, Inc., Zanesville
Local Institution, Guadalajara
Local Institution, Guadalajara
Local Institution, Zapopan
Providence Health Partners - Center For Clinical Research, Dayton
Northwest Indiana Center For Clinical Research, Valparaiso
St. Mary'S Center For Diabetes And Endocrinology, Grand Rapids
Cedar Crosse Research Center, Chicago
Local Institution, Monterrey
Local Institution, Monterrey, Nl
Professional Research Network Of Kansas, Wichita
Searcy Medical Center, Searcy
Little Rock Family Practice Clinic, Little Rock
Dallas Diabetes & Endocrine Center, Dallas
Village Family Practice, Houston
Office Of Dr. Michelle Zaniewski Singh, Houston
Diabetes & Glandular Disease Research Assoc,, Inc., San Antonio
Aurora Family Medicine Center, P.C., Aurora
Denver Internal Medicine, Denver
43rd Medical Associates, P.C., Phoenix
Clinical Research Advantage Inc / Desert Clinical Res, Llc, Tempe
Clinical Research Advantage, Inc, Tempe
Association Of International Professionals, Las Vegas
Randall Shue, D.O., Los Angeles
Torrance Clinical Research, Lomita
Diabetes Medical Center Of California, Northridge
Local Institution, Veracruz
Encompass Clinical Research, Spring Valley
Ritchken & First M.D.'S, San Diego
Desert Medical Advances, Palm Desert
Avastra Clinical Trials, Redlands
Clinical Innovations, Inc., Costa Mesa
Advantage Clinical Research, Santa Ana
Diabetes Research Center, Tustin
Marin Endocrine Care And Research, Inc., Greenbrae
Sierra Clinical Research, Roseville
Local Institution, Mérida
William L. Gray, Md, Spokane
Local Institution, Hariyāna
Local Institution, Mumbai
Local Institution, Vellore
Physicians Research Center, Toms River
Local Institution, Buenos Aires
Local Institution, Ciudad Auton
Local Institution, Winnipeg
Local Institution, Moncton
Local Institution, Mount Pearl
Local Institution, Halifax
Local Institution, Sarnia
Local Institution, Toronto
Local Institution, Mirabel
Local Institution, Lima
Local Institution, Ponce
Lead Sponsor
Collaborators (1)
Astra Zeneca, Bristol-Myers Squibb
OTHER
AstraZeneca
INDUSTRY